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Infection by pathogenic microorganisms triggers an acute phase response which manifests itself with fever, 
neuroendocrine changes and behavioral changes. Sepsis induced early impairment of neuronal metabolism and activity. 
Septic encephalopathy is a severe brain dysfunction caused by systemic inflammation in the absence of direct brain 
infection. Sepsis enhanced the transcription of several pro- and anti-inflammatory cytokines and chemokines including 
TNF-α, IL-1? and TGF-? in the cerebrum. Activated microglia during sepsis could play a role in behavioral changes 
associated with systemic infection. Changes in cerebral blood flow, release of inflammatory molecules and metabolic 
alterations contribute to neuronal dysfunction and cell death. 
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Sepsis is the most cause of death in the world, and as 
the cause of the highest in the patients in the Intensive 
Care Units (ICU), which incidence increased (Shahin et 
al. 2006). Up to 70% of patients sepsis may potential to 
develop into organs cerebral aberration function in acute 
(acute Cerebral dysfunction) (Wilson & Young 2003). 
This is the clarity that septic shock can be associated 
with damage or aberration function cerebral (Sharshar et 
al. 2004). 
 
The state of sepsis can trigger the occurrence of 
encephalopathy. Encephalopathy septic including sepsis 
into the clear, because in the sepsis is caused by the 
existence of systemic inflammation where the infection 
does not get the brain directly and obtained the 
characteristic clinical signs of a slowing of mental 
processes, which decreases awareness, disorientation, 
delirium and coma occur. And, most importantly that 
septic encephalopathy (SE) is an early sign of sepsis and 
associated with increased mortality and morbidity 
(Semmler et al. 2008). 
 
SE Pathogenesis conditions such as sepsis is not directly 
triggered by pathogenic toxin, in the SE this 
encephalopathy can develop as a result of the Systemic 
inflammatory Response Syndrome (SIRS), which 
causes the infection not found. Information from the 
experiment and clinic seen a number of factors such as 
cytokine pro-inflammation local, microcirculation 
cerebral weakness, imbalance neurotransmiter and the 
negative influence of organ peripheral failure contribute 
to an SE. Moreover, there is a settling of inflammation 
may cytotoxicity increase stress and oxidative further 
SE may cause a more severe, than that also play a role 
in the occurrence of deviation or slowdown neuronal 
function. Patients who have conditions pathologic on 
the central nervous system have previously may higher 
risk of going for the SE, and similar things can also be 
seen in an animal model of sepsis. Reciprocal 
interaction between the system behind the central 
nervous system and immunity is now considered as the 
main components of the host responds in shock septic. 
 
Sepsis pathophysiology is a result of complex 
interactions between the infection of pathogenic bacteria, 
inflammation and the coagulation is characterized as 
imbalance between cytokine proinflammation with 
cytokine anti-inflammation (Kristine et al. 2007). 
 
Reciprocal interaction between the system behind the 
central nervous system and immunity is now considered 
as the main components of the host responds in shock 
septic. Central nervous system is part of a special, 
because muscle is part of the immunity system such as 
the blood-brain barrier (BBB), the system lymphatic and 
parenchymal cells that play a role in expression of the 
complex with the antigen molecules major 
histocompatibility complex (MHC). Central nervous 
system to set up a wide physiological functions that are 
very important in the maintenance of homeostasis and 
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the setting of a complex host response to the level of 
autonomy, neuroendocrine and behavior. There is 
interference from some function adaptive will affect the 
shock septic. Need to be reviewed so that the brain areas 
involved in the response to infection, and the 
mechanism of interaction between brain and immunity 
during the shock septic, and clinical aspects of the 
aberration function cerebral the shock septic. 
 
 
NEUROPATHOLOGY OF SEPTIC SHOCK  
 
From the results of the research results indicate that 
autopsy of patients who died due to shock septic shows 
all visible ischemic lesion cases, bleeding (26%), 
hypercoagulability syndrome (9%), microabscess (9%), 
and multifocal necrotizing leucoencephalopathy (9%) 
related with the local expression of pro-cytokine and 
inflammation high degree cytokine pro-inflammation in 
circulation (Sharshar et al. 2004). This result shows that 
the central nervous system solely through the process 
can be broken inflammation, compared hypoperfusion 
or interference during coagulation shock septic 
(Sharshar et al. 2002). 
 
 
IMMUNITY-CENTRAL NERVOUS SYSTEM 
CHANNEL 
 
Immunity system is a system that is sensory may 
provide signal the existence of microorganisms to the 
central nervous system through three main channels. 
1. Circumventricular organs, which consists of a 
network and occupies a special bundle that strategic 
location. Because they are not protected by BBB, 
functioned as the structure of communication 
between the brain blood vessels (Goehler et al. 
2000). 
2. Vagal nerve, as the sensor inflammation in 
peripheral (through receptor cytokine located on the 
surface of the nerve), will convey information to 
the immunity and then medulla may inflammation 
pressing on the side of infection (through receptor 
nicotinic acetylcholine in the monocyte) (Wang et 
al. 2003). 
3. Activation and leakage endothelium, which will 
cause the release and diffusion passive mediator-




BLOOD-BRAIN BARRIER DURING INFECTION 
 
Results of the experiment in both the animal and try to 
show the human cytokine and lipopolysaccharide (LPS) 
both in peripheral and directly into the brain will be able 
to make changes and behavioral disturbances (Dantzer 
2004). Results from several observations indicate 
microglial cells plays an important role in the changes 
mediating behavior of the systemic infection (Lemstra 
et al. 2007). Cytokine pro-inflammation and LPS trigger 
the expression of CD40, vascular adhesion molecule-1 
or intercellular adhesion molecule-1, and E-selectin on 
the cell endothelial-vessel blood vessel in the brain 
(Omari & Dorovini-Zis 2003). It also causes the 
activation of genes transcript codes of cyclooxygenase-2 
(Cox-2) and stimulate path I? B/NF-? B. Although cells 
endothelial in the brain do not express CD14 on the 
surface, LPS is also able to trigger cascade mitogen-
activated protein kinase through a soluble CD14. Cells 
of the brain activated endothelial LPS may receptor 
express IL-1 and TNF-α; Produce IL-1, TNF-α and IL-
6; and secretes endothelial and inducible nitric oxid 
synthase (eNOS and iNOS) (Tarek et al. 2005). 
Mediators will interact with surrounding brain cells that 
will cause the response inflammation. This activation 
endothelium may BBB changes, so that there will be a 
deviation function cerebrovascular. Nitric oxide (NO), 
prostaglandin and cytokine set neutrotransmission brain, 
especially system-Adrenergic, production and release 
CRF, ACTH and vasopressin. Instead, neurotransmitter 
and neurohormone also set cerebral expression of 
mediator-mediator inflammation. (Dunn 2000; 
Matsuoko et al.. 2003). 
 
Most important aspect of apoptosis is cerebral 
dysfunction of brain cells, with the finding apoptosis 
cells and nerve microglia on hypothalamus and 
autonomous center in the brain of cardiovascular 
patients who died because of shock septic. Apoptosis of 
brain cells occurs as a consequence of various factors 
that play a role during shock septic including ischemia, 
glial cell activation, TNF-α, IL-1, Interferon-gamma 
and NO (Yuan & Yankner 2000). At intracellular, 
activation or retardation mitochondrial respiration, 
activation mitogen-activated protein kinase pathways 
and NF-1B, and release agents cytotoxic as calcium and 
reactive oxygen species (Ros) will be able to protect 





Encephalopathy on the prevalence of severe sepsis 
varies from 9% to 71%, depending on the level of 
severity based on clinical criteria, 
electroencephalographic (EEG) and its potential 
sensoric (Zauner et al. 2002). Where is the illness of this 
encephalopathy may disease associated with illness in 
general, its septic score (Acute Physiology and Chronic 
Health Evaluation II score / Apache score or the score 
from the organ failure), and its mortality. Many factors 
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that affect the pathophysiology of encephalopathy, 
including among others: 
a. Cerebral endothelial dysfunction may that result in 
a decrease Cerebral blood flow and BBB, increased 
translocation molecule-molecule neurotoxic and 
ischemic or hypoperfusion of the brain. 
b. Increasing the degree of amino acid neurotoxic 
(such as Amonium, tyrosin, triptophane and 
phenilalanine) in blood plasma, because of sepsis 
occur in the processes of reduction and proteolytic 
function of the liver. 
c. Inflammatiory mediators and endotoxin, which will 
lead to changes in cell metabolism and neuron-glial 
cells. So that the failure of kidney function and the 
liver, metabolic interference and the drugs that are 
neurotoxic may exaggerate speed and the 
occurrence of brain dysfunction (Tarek et al. 2005). 
Neurone-specific enolase is a sign of lesion in the 
brain, so it can be used as death predictor in septic-
shock patients (Weigand et al. 2000). 
 
 
NEUROENDOCRIN INTERFERENCE  
 
Response endocrin in sepsis is complex, in general, the 
severe sepsis that has been a disruption in the 
hypothalamic-pituitary path-adrenal, in which sepsis 
occurs insufficience adrenal may lead to a decrease in 
the sensitivity of the blood vessel vasopressors and 
increased risk of death. So that more of the shock 
cortisol may septic improve interference, this will 
increase its hemodynamic and survival. (Tarek et al. 
2005). 
 
Development of therapy with drugs will impact on the 
fundamental morbidity and sepsis mortality. The 
concept of modulation inflammation systemic response 
to sepsis caused a lot of heavy drugs anti-inflammation 
used in clinical trials. The provision of anti-endotoxin 
anti-CD14, anti-LBP, anti-platelet activating factor, 
anti-TNF, and anti-IL-1 does not show all of the 
improvement of life of sepsis. (Guntur 2008). 
Conversely, activated protein C, low dose corticosteroid, 
and intensive insulin therapy is able to reduce mortality 
has been proved and have started to receive patients 
management shock septic. So that the current research is 
to see growing levels of drug-drug interaction in the 
apoptosis pathways in the immune system (Wesche-
Soldato et al. 2007). 
 
Use corticosteroid as early as possible management 
recommended in sepsis, acute lung injury, acute 
respiratory distress syndrome and refractory 
vasodilatory shock (Aberdein & Singer 2006). From the 
results of the meta-analysis of research using high-dose 
steroid short term is not recommended in management 
shock septic, but recommends the use of low dose 
corticosteroid long-term (equivalent to 200 to 300 mg 
per day hydrocortison) (Annane et al. 2002). This is by 
opinion, which states that high-dose corticosteroid may 
pressing immune system, while increasing low-dose 
immune system. On the other studies reveal 
corticosteroid use as early as possible will increase the 
frequency of infection nosocomial, polymicrobial 
infection and fungus infection during treatment in the 
hospital. So corticosteroid may increase the risk of 
death or disability in patients with acute critical illness. 
(Rady et al. 2006). 
 
Catching the point of low-dose corticosteroid in sepsis, 
the response is inflammation systemic, as vasopressor, 
cytokine prevent the production pro-inflammation, 
preventing production of mediators, mediators 
inflammation as cyclooksigenase-2, lower leucocyte 
adhesion to the endothelium (Annane & Caillon 2003; 





Shock septic often leads to complications such as 
encephalopathy, neuroendocrine interference and failure 
cardiovascular a bad impact on the patient's sepsis. 
Interference mechanism is very complex and a clear 
signal mismatch occurs between the brain and immunity, 
which will generate activation brain cells, NO 
production disruption, dysfunction metabolism 
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